BlackRock Health Sciences Trust (BME) Income Statement
BME 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsBME revenue and net income
Where BME's revenue goes
2025Each bar shows an amount and its share of revenue. BME kept 212.9% of revenue as net income.
BME profit margins
BME growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +50.2% | — | −14.7% | −4.1% |
| Gross profit | +26.8% | — | −17.5% | −5.1% |
| Operating income | +228.3% | — | −0.7% | +8.7% |
| Net income | +228.2% | — | −0.7% | +8.7% |
| EPS (diluted) | +716.4% | — | −16.5% | +3.9% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
BME quarterly EPS vs estimates
BlackRock Health Sciences beat the analyst EPS estimate in 1 of the last 3 quarters.
BME income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $36.2M | $24.1M | $34.9M | $0 | $59.7M | $80.1M | $80.3M | $22.9M | $60.7M | $25.8M |
| Cost of revenue | $5.6M | $78 | $6.0M | $5.9M | $6.1M | $4.9M | $4.1M | $3.7M | $3.3M | $3.0M |
| Gross profit | $30.5M | $24.1M | $28.9M | −$26.0M | $59.7M | $80.1M | $80.3M | $22.9M | $60.7M | $22.8M |
| Research & development | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Sales, general & admin | $439,053 | $355,526 | $299,026 | $362,164 | $387,041 | $391,180 | $320,805 | $331,607 | $330,045 | $3.2M |
| Total operating expenses | −$46.5M | $617,092 | $393,597 | $500,130 | $541,459 | $531,493 | $413,567 | $446,618 | $392,044 | $19.6M |
| Operating income | $77.0M | $23.5M | $8.5M | −$26.5M | $59.1M | $79.6M | $79.9M | $22.4M | $60.3M | −$16.3M |
| Interest income | $0 | $0 | $0 | — | $59.1M | $79.5M | $79.2M | $21.8M | $60.2M | $16.5M |
| Interest expense | $45,688 | $78 | $55 | — | $0 | $0 | $0 | $0 | $0 | $0 |
| Income before taxes | $77.0M | $23.5M | $20.0M | −$26.5M | $59.1M | $79.6M | $79.9M | $22.4M | $60.3M | −$16.3M |
| Income taxes | — | — | $2.0M | $1.5M | $12,114 | $67,904 | $624,809 | −$161,141 | $200,146 | $5 |
| Net income | $77.0M | $23.5M | $20.0M | −$26.5M | $59.1M | $79.6M | $79.9M | $22.4M | $60.3M | −$16.3M |
| EBITDA | $77.0M | $23.5M | $20.0M | −$26.5M | $59.1M | $79.6M | $79.9M | $22.4M | $60.3M | −$16.2M |
| EPS (diluted) | $5.96 | $0.73 | $1.44 | −$5.29 | $14.86 | $14.70 | $51.51 | $2.28 | $6.49 | −$1.88 |
| Gross margin | 84.4% | 100.0% | 82.7% | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 88.4% |
| Operating margin | 212.9% | 97.4% | 24.3% | — | 99.1% | 99.3% | 99.5% | 98.0% | 99.4% | −63.0% |
| Net margin | 212.9% | 97.4% | 57.4% | — | 99.1% | 99.3% | 99.5% | 98.0% | 99.4% | −63.0% |
| Jun '26 | Dec '25 | Jun '25 | Dec '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 | Mar '23 | Dec '22 | Sep '22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $30.7M | $22.8M | $4.0M | $36.7M | $0 | $2.0M | $18.3M | $2.0M | $16.6M | $2.1M | $538,987 | $2.0M |
| Cost of revenue | $2.8M | $2.9M | $2.8M | $3.3M | $3.1M | $0 | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M |
| Gross profit | $28.0M | $19.9M | $4.0M | $33.4M | −$3.5M | $2.0M | $15.3M | $2.0M | $13.6M | $2.1M | −$2.5M | $2.0M |
| Sales, general & admin | $2.8M | $2.5M | $3.0M | $55.9M | $3.2M | $1.6M | $6.6M | $1.6M | $2.3M | $1.5M | $1.6M | $1.6M |
| Total operating expenses | $4.5M | −$60.7M | $3.0M | $55.9M | −$49.4M | $1.6M | $6.6M | $2.4M | $2.3M | $3.5M | $15.9M | $15.9M |
| Operating income | $23.5M | $80.6M | $968,598 | −$22.5M | $46.0M | $429,142 | $8.7M | $415,919 | $11.3M | $586,870 | $35.8M | $402,217 |
| Interest expense | $16,850 | $21,152 | $87 | — | — | — | $55 | $55 | — | — | — | — |
| Income before taxes | $23.5M | $80.5M | −$3.6M | −$22.5M | $45.9M | $23.0M | $8.7M | $4.4M | $11.3M | $5.7M | $35.8M | $17.9M |
| Income taxes | — | — | — | — | $46.0M | — | $1 | $3.9M | $1 | $5.1M | $3 | $17.5M |
| Net income | $23.5M | $80.5M | −$3.6M | −$22.5M | $45.9M | $23.0M | $8.7M | $4.4M | $11.3M | $5.7M | $35.8M | $17.9M |
| EBITDA | $23.5M | $80.6M | $968,598 | −$22.5M | $46.0M | — | $8.7M | $3.9M | $11.3M | $5.1M | $35.8M | $17.5M |
| EPS (diluted) | — | — | −$0.28 | −$1.79 | — | — | — | — | — | — | $2.52 | — |
| Gross margin | 91.1% | 87.4% | 100.0% | 91.1% | — | 100.0% | 83.5% | 100.0% | 81.9% | 100.0% | −456.5% | 100.0% |
| Operating margin | 76.4% | 354.0% | 24.5% | −61.2% | — | 21.2% | 47.6% | 21.1% | 68.1% | 27.6% | 6,646.1% | 20.3% |
| Net margin | 76.4% | 353.9% | −90.0% | −61.3% | — | 1,133.1% | 47.6% | 221.2% | 68.1% | 265.6% | 6,644.7% | 902.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in BME's financial statements (latest annual report filed December 31, 2025); data from EODHD. Sales, general & administrative expenses include sales and marketing.
BME financial results
In fiscal year 2025 (ended December 31, 2025), BlackRock Health Sciences reported revenue of $36.2 million, up 50.2% from the year before. It had net income of $77.0 million (up 228.2%), a net profit margin of 212.9%. Diluted earnings per share came to $5.96. Over five years revenue grew at an average rate of −14.7% a year.
See the BME stock overview for the latest quote and news, or the BME chart for price history and technical indicators.
BME income statement FAQ
What is BlackRock Health Sciences's annual revenue?
BlackRock Health Sciences reported total revenue of $36.2 million for fiscal year 2025, which ended on December 31, 2025. That was up 50.2% from $24.1 million the previous year.
Is BlackRock Health Sciences profitable?
Yes. BlackRock Health Sciences reported net income of $77.0 million in fiscal 2025, a net profit margin of 212.9%; its operating margin was 212.9%.
What is BlackRock Health Sciences's gross margin?
BlackRock Health Sciences's gross margin was 84.4% in fiscal 2025: for every $100 of revenue, BlackRock Health Sciences kept $84 after the direct cost of its products and services.
How fast is BlackRock Health Sciences growing?
Revenue grew −14.7% a year on average over the last five fiscal years, from $80.1 million to $36.2 million.
What are BlackRock Health Sciences's earnings per share?
BlackRock Health Sciences earned $5.96 per diluted share in fiscal 2025, compared with $0.73 a year earlier.
When does BlackRock Health Sciences's fiscal year end?
BlackRock Health Sciences's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on December 31, 2025.